Bartlett DL - Search Results

1

Development of a replication-selective, oncolytic poxvirus for the treatment of human cancers.

Zeh HJ, Bartlett DL. Zeh HJ, et al. Among authors: bartlett dl. Cancer Gene Ther. 2002 Dec;9(12):1001-12. doi: 10.1038/sj.cgt.7700549. Cancer Gene Ther. 2002. PMID: 12522439 Review.

2

Thymidine kinase-deleted vaccinia virus expressing purine nucleoside phosphorylase as a vector for tumor-directed gene therapy.

Puhlmann M, Gnant M, Brown CK, Alexander HR, Bartlett DL. Puhlmann M, et al. Among authors: bartlett dl. Hum Gene Ther. 1999 Mar 1;10(4):649-57. doi: 10.1089/10430349950018724. Hum Gene Ther. 1999. PMID: 10094208

3

Gadolinium-enhanced 3D MRA prior to isolated hepatic perfusion for metastases.

Zeh H, Choyke PL, Alexander HR, Bartlett DL, Libutti SK, Chang R, Summers RM. Zeh H, et al. Among authors: bartlett dl. J Comput Assist Tomogr. 1999 Sep-Oct;23(5):664-9. doi: 10.1097/00004728-199909000-00003. J Comput Assist Tomogr. 1999. PMID: 10524842

4

Vaccinia as a vector for tumor-directed gene therapy: biodistribution of a thymidine kinase-deleted mutant.

Puhlmann M, Brown CK, Gnant M, Huang J, Libutti SK, Alexander HR, Bartlett DL. Puhlmann M, et al. Among authors: bartlett dl. Cancer Gene Ther. 2000 Jan;7(1):66-73. doi: 10.1038/sj.cgt.7700075. Cancer Gene Ther. 2000. PMID: 10678358

5

Complex interactions between the replicating oncolytic effect and the enzyme/prodrug effect of vaccinia-mediated tumor regression.

McCart JA, Puhlmann M, Lee J, Hu Y, Libutti SK, Alexander HR, Bartlett DL. McCart JA, et al. Among authors: bartlett dl. Gene Ther. 2000 Jul;7(14):1217-23. doi: 10.1038/sj.gt.3301237. Gene Ther. 2000. PMID: 10918490

6

Systemic cancer therapy with a tumor-selective vaccinia virus mutant lacking thymidine kinase and vaccinia growth factor genes.

McCart JA, Ward JM, Lee J, Hu Y, Alexander HR, Libutti SK, Moss B, Bartlett DL. McCart JA, et al. Among authors: bartlett dl. Cancer Res. 2001 Dec 15;61(24):8751-7. Cancer Res. 2001. PMID: 11751395

7

Development of a melanoma-specific adenovirus.

McCart JA, Wang ZH, Xu H, Hu Y, Park B, Alexander HR, Bartlett DL. McCart JA, et al. Among authors: bartlett dl. Mol Ther. 2002 Oct;6(4):471-80. doi: 10.1006/mthe.2002.0692. Mol Ther. 2002. PMID: 12377188 Free article.

8

Vaccinia as a vector for gene delivery.

Guo ZS, Bartlett DL. Guo ZS, et al. Among authors: bartlett dl. Expert Opin Biol Ther. 2004 Jun;4(6):901-17. doi: 10.1517/14712598.4.6.901. Expert Opin Biol Ther. 2004. PMID: 15174972 Review.

9

Targeting vaccinia to solid tumors with local hyperthermia.

Chang E, Chalikonda S, Friedl J, Xu H, Phan GQ, Marincola FM, Alexander HR, Bartlett DL. Chang E, et al. Among authors: bartlett dl. Hum Gene Ther. 2005 Apr;16(4):435-44. doi: 10.1089/hum.2005.16.435. Hum Gene Ther. 2005. PMID: 15871675

10

The use of oncolytic vaccinia viruses in the treatment of cancer: a new role for an old ally?

Thorne SH, Bartlett DL, Kirn DH. Thorne SH, et al. Among authors: bartlett dl. Curr Gene Ther. 2005 Aug;5(4):429-43. doi: 10.2174/1566523054546215. Curr Gene Ther. 2005. PMID: 16101516 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

410 results

Search Page

Filters